Ascend Capital’s Delek US DK Stock Holding History

Ascend Capital’s Portfolio DK Stock Details DK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$13.6M	Buy	319,863 +137,530	+75%	+$6.79M	0.68%	52
2018 Q2	$9.15M	Buy	+182,333	New	+$9.07M	0.43%	77

Other funds holding DK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Ascend Capital's DK Position: Q3 2018 in Review

Ascend Capital increased its Delek US (DK) stake by 75% in Q3 2018, buying an estimated $6.79M and bringing the position to 319,863 shares worth $13.6M. The position accounts for 0.68% of the portfolio, ranked #52.

Ascend Capital first reported a position in DK in Q2 2018 and has held it in 2 quarters since. 280 funds tracked by Wall St. Rank hold DK as of Q3 2018.

Ascend Capital held 319,863 shares of Delek US worth $13.6M as of Q3 2018.
Ascend Capital bought 137,530 Delek US shares in Q3 2018, an estimated $6.79M.
Delek US made up 0.68% of Ascend Capital's portfolio in Q3 2018, its #52 holding.
Ascend Capital first reported a position in Delek US in Q2 2018 and has held it in 2 quarters since.
280 funds tracked by Wall St. Rank held Delek US as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.